Merrimack Pharmaceuticals is a biopharmaceutical company discovering, developing and preparing to commercialize innovative medicines paired with companion diagnostics for the treatment of cancer. Merrimack applies Network Biology, its proprietary systems biology-based approach to biomedical research, throughout the research and development process. Merrimack currently has six oncology therapeutics in clinical development.
Contacts
Kathleen Petrozzelli Gallagher
Merrimack Pharmaceuticals
617-441-1043
kgallagher@merrimackpharma.com
Liz Bryan
Spectrum
202-955-6222
lbryan@spectrumscience.com